Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients

Journal of Heart and Lung Transplantation

Volumn 25, Issue 4, 2006, Pages 434-439

  Kobashigawa, Jon A ^a,b   Patel, J ^a   Furukawa, H ^a   Moriguchi, J D ^a   Yeatman, L ^a   Takemoto, S ^a   Marquez, A ^a   Shaw, J ^a   Oeser, B T ^a   Subherwal, S ^a   Wu, G W ^a   Kawano, J ^a   Laks, H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CHOLESTEROL; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; TRIACYLGLYCEROL; TSUKUBAENOLIDE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG FORMULATION; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MICROEMULSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTIHYPERTENSIVE AGENTS; CORONARY STENOSIS; CYCLOSPORINE; EMULSIONS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33645076062     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2005.11.452     Document Type: Article

References (27)

1. P.E. Oyer, E.B. Stinson, S.W. Jamison Cyclosporin-A in cardiac allografting a preliminary experience Transplant Proc 15 1983 1247 1252
2. M.T. Grattan, C.E. Moreno-Cabral, V.A. Starnes Eight-year results of cyclosporine-treated patients with cardiac transplants J Thorac Cardiovasc Surg 99 1990 500 509
3. M. Hakim, J. Wallwork, T. English Cyclosporin A in cardiac transplantation medium-term results in 62 patients Ann Thorac Surg 46 1988 495 501
4. G.L. Plosker, R.H. Foster Tacrolimus a further update of its pharmacology and therapeutic use in the management of organ transplantation Drugs 59 2000 323 329
5. A. Keogh Calcineurin inhibitors in heart transplantation J Heart Lung Transplant 23 suppl 2004 S202 S206
6. T.E. Starzl, S. Todo, J. Fung FK506 for liver, kidney, and pancreas transplantation Lancet 1989 1000 1004 ii
7. G.M. Verleden, L.J. Dupont, D. Van Raemdonck Effect of switching from cyclosporine to tacrolimus on exhaled nitric oxide and pulmonary function in patients with chronic rejection after lung transplantation J Heart Lung Transplant 22 2003 908 913
8. D.A. Baran, I. Galin, D. Sandler Tacrolimus in cardiac transplantation efficacy and safety of a novel dosing protocol Transplantation 74 2002 1136 1141
9. M. White, H. Haddad, M.H. Leblanc Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia the Canadian Multicentre Randomized Trial of Tacrolimus vs Cyclosporine Microemulsion J Heart Lung Transplant 24 2005 798 809
10. B. Cantin, B.W. Kwok, N. Shiba Post-operative conversion from cyclosporine to tacrolimus in heart transplantation a single-center experience J Heart Lung Transplant 22 2003 723 730
11. J.M. Armitage, R.L. Kormos, S. Morita Clinical trial of FK506 immunosuppression in adult cardiac transplantation Ann Thorac Surg 54 1992 205 211
12. S.M. Pham, R.L. Kormos, B.G. Hattler A prospective trial of tacrolimus (FK506) in clinical heart transplantation intermediate-term results J Thorac Cardiovasc Surg 111 1996 764 772
13. D.O. Taylor, M.L. Barr, B. Radovancevic A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation decreased hyperlipidemia and hypertension with tacrolimus J Heart Lung Transplant 18 1999 336 345
14. B. Reichart, B. Meiser, M. Vigano European multicenter tacrolimus (FK506) heart pilot study one-year results-European tacrolimus multicenter heart study group J Heart Lung Transplant 17 1998 775 781
15. S. Noble, A. Markham Cyclosporin a review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral) Drugs 50 1995 924 941
16. H.J. Eisen, R.E. Hobbs, S.F. Davis Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine-results at six months after transplantation Transplantation 68 1999 663 671
17. J. Kobashigawa Controversies in heart and lung transplantation immunosuppression tacrolimus versus cyclosporine Transplant Proc 30 1998 1095 1097
18. M.E. Billingham, N.R. Cary, M.E. Hammond A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection heart rejection study group J Heart Transplant 9 1990 587 593
19. J. Kobashigawa, L. Wener, J. Johnson Longitudinal study of vascular remodeling in coronary arteries after heart transplantation J Heart Lung Transplant 19 2000 546 550
20. H.J. Eisen, R.E. Hobbs, S.F. Davis Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine-results at 24 months after transplantation Transplantation 71 2001 70 78
21. B.M. Meiser, P. Überfuhr, A. Fuchs Single-center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection J Heart Lung Transplant 17 1998 782 788
22. V. Klauss, A. König, C. Spes Cyclosporine versus tacrolimus (FK506) for prevention of cardiac allograft vasculopathy Am J Cardiol 85 2000 266 269
23. M. Rinaldi, C. Pellegrini, L. Martinelli FK506 effectiveness in reducing acute rejection after heart transplantation a prospective randomized study J Heart Lung Transplant 16 1997 1001 1010
24. M. Grimm, M. Rinaldi, N.A. Yonan Efficacy and safety of tacrolimus (TAC) vs. cyclosporine microemulsion (CME) in de novo cardiac transplantation recipients 6-month results J Heart Lung Transplant 22 suppl 2003 S92
25. J. Groetzer, B. Meiser, J. Schirmer Tacrolimus/mycophenolate mofetil vs cyclosporine/mycophenolate mofetil impact on infections following cardiac transplantation J Heart Lung Transplant 22 suppl 2003 S120
26. P.A. Uber, M.R. Mehra, R.L. Scott, A.K. Prasa, M.H. Park Ethnic disparities in the pharmacologic characteristics of tacrolimus in heart transplantation Transplant Proc 33 2001 1581 1582
27. M.R. Mehra, P.A. Uber, R.L. Scott, A.K. Prasa, M.H. Park Racial differences in clinical outcome using tacrolimus and mycophenolate mofetil immunosuppression in heart transplantation Transplant Proc 33 2001 1613 1614